TipRanks
Go Ultimate55% OFF

Zenas BioPharma, Inc. (ZBIO) Income Statement

Zenas BioPharma, Inc. Income Statement

Last quarter (Q2 2026), Zenas BioPharma, Inc.'s total revenue was $1.00M. In Q2, Zenas BioPharma, Inc.'s net income was $-111.46M. See Zenas BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22
$ 10.00M$ 5.00M$ 50.00M$ 0.00
$ 10.00M$ -134.14M$ 50.00M$ -61.69M
$ 221.38M$ 29.75M$ 87.15M$ 14.51M
Depreciation and Amortization$ 56.00K$ 137.00K$ 113.00K$ 78.00K
$ -370.43M$ -156.42M$ -27.03M$ -75.12M
$ -211.38M$ -163.89M$ -37.15M$ -76.20M
$ -166.43M$ 7.33M$ 324.00K$ -43.08M
$ -377.82M$ -156.56M$ -36.82M$ -119.28M
$ -377.74M$ -156.99M$ -37.12M$ -119.28M
Per Share Metrics
Basic EPS$ -8.44$ -3.76$ -0.97$ -3.11
Diluted EPS$ -8.44$ -3.76$ -0.97$ -3.11
Weighted Average Shares Outstanding44.73M41.79M38.32M38.32M
Weighted Average Shares Outstanding (Diluted)44.73M41.79M38.32M38.32M

Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History

-400M-200M0200M-4500 %-3000 %-1500 %0 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin